Gyre Therapeutics (GYRE) Operating Income: 2009-2025
Historic Operating Income for Gyre Therapeutics (GYRE) over the last 16 years, with Sep 2025 value amounting to $6.9 million.
- Gyre Therapeutics' Operating Income rose 63.60% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 115.81%. This contributed to the annual value of $16.2 million for FY2024, which is 124.04% up from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Operating Income is $6.9 million, which was up 218.98% from $2.2 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Operating Income registered a high of $51.5 million during Q2 2022, and its lowest value of -$91.6 million during Q4 2023.
- Its 3-year average for Operating Income is -$3.6 million, with a median of $4.2 million in 2024.
- Per our database at Business Quant, Gyre Therapeutics' Operating Income slumped by 342.74% in 2021 and then skyrocketed by 358.76% in 2022.
- Quarterly analysis of 5 years shows Gyre Therapeutics' Operating Income stood at -$20.3 million in 2021, then declined by 10.57% to -$22.5 million in 2022, then crashed by 307.98% to -$91.6 million in 2023, then soared by 100.73% to $665,000 in 2024, then surged by 63.60% to $6.9 million in 2025.
- Its last three reported values are $6.9 million in Q3 2025, $2.2 million for Q2 2025, and $2.3 million during Q1 2025.